LALBA and type 2 diabetes mellitus: Two peptides were annotated with dipeptidyl peptidase-IV (DPP-IV)-inhibitory activity, with one from alpha-lactalbumin showing an IC50 of 13.8 μM, indicating potential for glucose metabolism regulation and Type 2 diabetes management.